首页 > 最新文献

Journal of Community Hospital Internal Medicine Perspectives最新文献

英文 中文
Gastric Adenocarcinoma With Enteroblastic Differentiation Presenting as Lung Nodules: A Diagnostic Dilemma. 胃腺癌伴肠母细胞分化表现为肺结节:诊断困境。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1548
Jain Evani, Yadav Devvrat, Sainatham Chiranjeevi, Kc Manisha, Jain Anirudh, Jindal Vishal

Background: Gastric Adenocarcinoma with enteroblastic differentiation (GAED) is a rare subtype of alpha fetoprotein-producing gastric cancers characterized by a tubulo-papillary pattern resembling fetal gastrointestinal epithelium. It expresses at least one of the following enteroblastic markers (EMs): glypican-3 (GPC3), spalt-like transcription factor 4 (SALL4), and α-fetoprotein (AFP).

Case report: A 78-year-old man with a history of chronic dry cough was found to have multiple lung nodules on Chest X-ray and CT, suspicious for a malignancy. Therefore, percutaneous biopsy of the lung nodule was performed which showed CDX-2 positivity on immunohistochemistry (IHC). Next Generation Sequencing (NGS) and Caris GPSai were inconclusive. Therefore, a search for the primary site was initiated. Endoscopy revealed a fungating mass at the gastroesophageal junction while colonoscopy was unrevealing. Histology revealed well-differentiated adenocarcinoma with mucinous features. IHC was positive for SALL-4 and GPC3. HER2 expression returned a 3+ score. Alpha-fetoprotein (AFP) level was elevated. The patient was started on capecitabine and oxaliplatin in addition to trastuzumab with subsequent clinical and radiological improvement.

Conclusion: Lung malignancy, primary or metastatic, can present as chronic cough. It is imperative for patients to undergo a thorough workup for a timely diagnosis. IHC plays a vital role in delineating the origin of the malignant cells. GPC3 expression is the most sensitive marker for GAED. High serum AFP levels directly correlate with the strength of immunostaining and are associated with a poor prognosis. High HER2 expression and PDL-1 immunostaining is commonly seen in GAED cases with the most common mutation being p53. Currently, there are no set guidelines for management of GAED. Unresectable, metastatic HER2 positive conventional adenocarcinoma is being managed using platinum-fluoropyrimidine doublet therapy with anti-HER2 monoclonal antibody trastuzumab. This case report calls for aggressive IHC staining for prompt diagnosis where necessary as well as proper guidelines for management.

背景:胃腺癌伴肠母细胞分化(GAED)是一种罕见的产α胎蛋白胃癌亚型,其特征为类似胎儿胃肠道上皮的管状-乳头状结构。它表达至少一种以下肠母细胞标记物(EMs): glypican-3 (GPC3)、splalt样转录因子4 (SALL4)和α-胎蛋白(AFP)。病例报告:78岁男性,有慢性干咳史,胸部x线及CT检查发现多发肺结节,怀疑为恶性肿瘤。因此,经皮肺结节活检显示CDX-2免疫组化(IHC)阳性。Next Generation Sequencing (NGS)和Caris GPSai尚无定论。因此,启动了对主站点的搜索。内窥镜检查显示胃食管交界处有一个真菌团块,而结肠镜检查未发现。组织学表现为高分化腺癌,具有黏液特征。免疫组化检测small -4和GPC3阳性。HER2表达返回3+分。甲胎蛋白水平升高。患者在曲妥珠单抗的基础上开始使用卡培他滨和奥沙利铂,随后临床和放射学改善。结论:原发性或转移性肺恶性肿瘤均可表现为慢性咳嗽。为了及时诊断,患者必须进行彻底的检查。免疫组化在描述恶性细胞的起源方面起着至关重要的作用。GPC3表达是GAED最敏感的标志物。高血清AFP水平与免疫染色强度直接相关,并与预后不良相关。高HER2表达和PDL-1免疫染色常见于GAED病例,最常见的突变是p53。目前,对于GAED的管理没有固定的指导方针。不可切除的、转移性HER2阳性的常规腺癌正在使用铂-氟嘧啶双重疗法联合抗HER2单克隆抗体曲妥珠单抗进行治疗。本病例报告呼吁积极免疫组化染色,以便在必要时及时诊断,并提供适当的管理指南。
{"title":"Gastric Adenocarcinoma With Enteroblastic Differentiation Presenting as Lung Nodules: A Diagnostic Dilemma.","authors":"Jain Evani, Yadav Devvrat, Sainatham Chiranjeevi, Kc Manisha, Jain Anirudh, Jindal Vishal","doi":"10.55729/2000-9666.1548","DOIUrl":"https://doi.org/10.55729/2000-9666.1548","url":null,"abstract":"<p><strong>Background: </strong>Gastric Adenocarcinoma with enteroblastic differentiation (GAED) is a rare subtype of alpha fetoprotein-producing gastric cancers characterized by a tubulo-papillary pattern resembling fetal gastrointestinal epithelium. It expresses at least one of the following enteroblastic markers (EMs): glypican-3 (GPC3), spalt-like transcription factor 4 (SALL4), and α-fetoprotein (AFP).</p><p><strong>Case report: </strong>A 78-year-old man with a history of chronic dry cough was found to have multiple lung nodules on Chest X-ray and CT, suspicious for a malignancy. Therefore, percutaneous biopsy of the lung nodule was performed which showed CDX-2 positivity on immunohistochemistry (IHC). Next Generation Sequencing (NGS) and Caris GPSai were inconclusive. Therefore, a search for the primary site was initiated. Endoscopy revealed a fungating mass at the gastroesophageal junction while colonoscopy was unrevealing. Histology revealed well-differentiated adenocarcinoma with mucinous features. IHC was positive for SALL-4 and GPC3. HER2 expression returned a 3+ score. Alpha-fetoprotein (AFP) level was elevated. The patient was started on capecitabine and oxaliplatin in addition to trastuzumab with subsequent clinical and radiological improvement.</p><p><strong>Conclusion: </strong>Lung malignancy, primary or metastatic, can present as chronic cough. It is imperative for patients to undergo a thorough workup for a timely diagnosis. IHC plays a vital role in delineating the origin of the malignant cells. GPC3 expression is the most sensitive marker for GAED. High serum AFP levels directly correlate with the strength of immunostaining and are associated with a poor prognosis. High HER2 expression and PDL-1 immunostaining is commonly seen in GAED cases with the most common mutation being p53. Currently, there are no set guidelines for management of GAED. Unresectable, metastatic HER2 positive conventional adenocarcinoma is being managed using platinum-fluoropyrimidine doublet therapy with anti-HER2 monoclonal antibody trastuzumab. This case report calls for aggressive IHC staining for prompt diagnosis where necessary as well as proper guidelines for management.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"61-65"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JCHIMP 15th Anniversary Issue: Peer Review, Authorship and Scholarly Activity. JCHIMP 15周年特刊:同行评议、作者身份和学术活动。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1558
Surendra Marur, Lucien J Cardinal, Gillian Junker

JCHIMP's Editor-in-Chief and a member of the Editorial Board acknowledge the importance of authors and peer reviewers to the success of JCHIMP in 2024. They discuss the value of peer review and how it satisfies ACGME directives for scholarship. Publication costs, and sources for publication funding are also examined.

JCHIMP的总编辑和编委会成员承认作者和同行评审对JCHIMP在2024年取得成功的重要性。他们讨论了同行评议的价值,以及它如何满足ACGME对奖学金的要求。还审查了出版费用和出版经费的来源。
{"title":"JCHIMP 15th Anniversary Issue: Peer Review, Authorship and Scholarly Activity.","authors":"Surendra Marur, Lucien J Cardinal, Gillian Junker","doi":"10.55729/2000-9666.1558","DOIUrl":"https://doi.org/10.55729/2000-9666.1558","url":null,"abstract":"<p><p>JCHIMP's Editor-in-Chief and a member of the Editorial Board acknowledge the importance of authors and peer reviewers to the success of JCHIMP in 2024. They discuss the value of peer review and how it satisfies ACGME directives for scholarship. Publication costs, and sources for publication funding are also examined.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880939/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A not too Fragile Bacteroides. 一种不太脆弱的拟杆菌。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1554
Siddartha Guru, Nadim Jaafar, Rahul Sharma, Poonam Bai

We present a rare case of Bacteroides fragilis vertebral osteomyelitis, in a 20-year-old female with no underlying medical conditions. She presented with a three-week history of lower back pain, myalgias, rigors, and night sweats. The patient was febrile and tachycardic, with borderline low blood pressures. Her initial labs showed elevated inflammatory markers with no leukocytosis. MRI of the thoracic and lumbar spine demonstrated T12/L1 discitis/osteomyelitis with phlegmonous changes and concerns for epidural abscess, causing mild to moderate spinal stenosis. Bacteroides fragilis grew in an anaerobic bottle, and a CT-guided biopsy of the T12/L1 lesion grew Bacteroides fragilis. E-test sensitivities revealed sensitivity to metronidazole. The source of bacteremia was thought to be from gut translocation thus concerned about possible co-infection with E. coli from the gastrointestinal tract. Another source of E. coli could have been from her recent E. coli urinary tract infection, whose growth from blood cultures could have been suppressed from recent course of cephalexin. She was treated with six weeks of metronidazole for the Bacteroides fragilis and ceftriaxone for possible co-infection with E. coli, resulting in improvement of her back pain and down-trending inflammatory markers on clinic follow-up after six weeks.

我们报告一例罕见的脆性拟杆菌椎体骨髓炎病例,患者为20岁女性,无基础医学条件。她有三周的腰痛、肌痛、僵硬和盗汗病史。患者发热、心动过速,伴有边缘性低血压。她最初的化验显示炎症标志物升高,无白细胞增多。胸椎和腰椎MRI显示T12/L1椎间盘炎/骨髓炎伴痰样改变和硬膜外脓肿,引起轻度至中度椎管狭窄。在厌氧瓶中生长脆弱拟杆菌,ct引导下活检T12/L1病变处生长脆弱拟杆菌。e -试验敏感性显示对甲硝唑敏感。菌血症的来源被认为是肠道易位,因此担心可能与胃肠道的大肠杆菌合并感染。大肠杆菌的另一个来源可能来自她最近的大肠杆菌尿路感染,其血液培养的生长可能因最近服用头孢氨苄而受到抑制。患者给予甲硝唑治疗脆弱拟杆菌6周,头孢曲松治疗可能合并大肠杆菌感染6周,6周后临床随访,患者背部疼痛有所改善,炎症指标呈下降趋势。
{"title":"A not too Fragile Bacteroides.","authors":"Siddartha Guru, Nadim Jaafar, Rahul Sharma, Poonam Bai","doi":"10.55729/2000-9666.1554","DOIUrl":"https://doi.org/10.55729/2000-9666.1554","url":null,"abstract":"<p><p>We present a rare case of <i>Bacteroides fragilis</i> vertebral osteomyelitis, in a 20-year-old female with no underlying medical conditions. She presented with a three-week history of lower back pain, myalgias, rigors, and night sweats. The patient was febrile and tachycardic, with borderline low blood pressures. Her initial labs showed elevated inflammatory markers with no leukocytosis. MRI of the thoracic and lumbar spine demonstrated T12/L1 discitis/osteomyelitis with phlegmonous changes and concerns for epidural abscess, causing mild to moderate spinal stenosis. <i>Bacteroides fragilis</i> grew in an anaerobic bottle, and a CT-guided biopsy of the T12/L1 lesion grew <i>Bacteroides fragilis</i>. E-test sensitivities revealed sensitivity to metronidazole. The source of bacteremia was thought to be from gut translocation thus concerned about possible co-infection with <i>E. coli</i> from the gastrointestinal tract. Another source of <i>E. coli</i> could have been from her recent <i>E. coli</i> urinary tract infection, whose growth from blood cultures could have been suppressed from recent course of cephalexin. She was treated with six weeks of metronidazole for the <i>Bacteroides fragilis</i> and ceftriaxone for possible co-infection with <i>E. coli</i>, resulting in improvement of her back pain and down-trending inflammatory markers on clinic follow-up after six weeks.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"45-48"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling the Downhill Spiral: A Tale of Alcohol, Varices, and a Hidden Stenosis. 解开下坡螺旋:一个关于酒精、静脉曲张和隐性狭窄的故事。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1553
Edris Adel, Urwah Ahmad, Ramya Vasireddy, Jasmine Barrow

Downhill esophageal varices (EVs) were first described in 1964 by Felson and Lessure. They are rare with an incidence rate of 0.5 % in the general population. They usually develop due to an increase in pressure and/or obstruction of the superior vena cava (SVC) and rarely present with hematemesis. SVC syndrome, surgical ligation of the SVC, Castleman syndrome, pulmonary hypertension, and hypercontractile esophageal motility disorders can cause this. We report a case of downhill EVs in an older male with alcohol use disorder with incidental finding of SVC stenosis secondary to an old, unused chemotherapy port.

下坡食道静脉曲张(EVs)于1964年由Felson和Lessure首次描述。它们很罕见,在一般人群中的发病率为0.5%。它们通常是由于压力增加和/或上腔静脉阻塞(SVC)而发展的,很少出现呕血。SVC综合征、SVC结扎术、Castleman综合征、肺动脉高压和食道运动过度收缩性障碍均可引起此症状。我们报告一个老年男性酒精使用障碍患者的下坡EVs病例,偶然发现SVC狭窄继发于旧的,未使用的化疗端口。
{"title":"Unravelling the Downhill Spiral: A Tale of Alcohol, Varices, and a Hidden Stenosis.","authors":"Edris Adel, Urwah Ahmad, Ramya Vasireddy, Jasmine Barrow","doi":"10.55729/2000-9666.1553","DOIUrl":"https://doi.org/10.55729/2000-9666.1553","url":null,"abstract":"<p><p>Downhill esophageal varices (EVs) were first described in 1964 by Felson and Lessure. They are rare with an incidence rate of 0.5 % in the general population. They usually develop due to an increase in pressure and/or obstruction of the superior vena cava (SVC) and rarely present with hematemesis. SVC syndrome, surgical ligation of the SVC, Castleman syndrome, pulmonary hypertension, and hypercontractile esophageal motility disorders can cause this. We report a case of downhill EVs in an older male with alcohol use disorder with incidental finding of SVC stenosis secondary to an old, unused chemotherapy port.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"30-33"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Cases of Intramyocardial Dissecting Hematoma Diagnosed by Echocardiography. 超声心动图诊断心内夹层血肿2例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1521
Jianbo Wu, Fei Bian, Xijun Zhu, Xin Du, Tao Hao, Qian Liu

Intramyocardial dissecting hematoma (IDH), a rare complication of myocardial infarction, was investigated through two unique clinical cases in this study. We demonstrate echocardiography's pivotal role in emergency diagnostics by detailing its critical contribution to rapid identification. Furthermore, we propose a hypothesis regarding the anatomical subtypes of IDH, potentially offering new perspectives and insights into this rare cardiac condition.

本文通过两个独特的临床病例对心肌梗死的罕见并发症心内解剖血肿(IDH)进行了研究。我们通过详细说明超声心动图对快速识别的关键贡献,展示了超声心动图在急诊诊断中的关键作用。此外,我们提出了一个关于IDH解剖亚型的假设,可能为这种罕见的心脏病提供新的视角和见解。
{"title":"Two Cases of Intramyocardial Dissecting Hematoma Diagnosed by Echocardiography.","authors":"Jianbo Wu, Fei Bian, Xijun Zhu, Xin Du, Tao Hao, Qian Liu","doi":"10.55729/2000-9666.1521","DOIUrl":"https://doi.org/10.55729/2000-9666.1521","url":null,"abstract":"<p><p>Intramyocardial dissecting hematoma (IDH), a rare complication of myocardial infarction, was investigated through two unique clinical cases in this study. We demonstrate echocardiography's pivotal role in emergency diagnostics by detailing its critical contribution to rapid identification. Furthermore, we propose a hypothesis regarding the anatomical subtypes of IDH, potentially offering new perspectives and insights into this rare cardiac condition.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"34-39"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life Changes Post-PCI With Contrast-induced Nephropathy. 造影剂肾病患者pci术后生活质量的改变。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1545
Uzair N Malik, Kashif Iltaf, Maria M Ahmed Babiker, Prem Chand, Rakesh Kumar, Areesha Qureshi, Aajay Kumar, Muhammad H Bari, Ali Karim, Sameet Kumar, Fnu Shweta, Fnu Rumela, Fnu Payal, Abida Parveen

Objective: This study aimed to evaluate the impact of contrast-induced nephropathy (CIN) on quality of life (QoL) in patients undergoing percutaneous coronary intervention (PCI) in Pakistan.

Methods: A retrospective cohort study was conducted involving 5325 patients who underwent PCI, divided into CIN (n = 1250) and non-CIN (n = 4075) groups. Demographics, clinical characteristics, and procedural details were recorded. QoL was assessed using a standardized questionnaire before and after PCI, covering physical functioning, pain, mobility, anxiety/depression, and overall health. Statistical analyses compared QoL scores between groups and identified predictors of change.

Results: Patients who developed CIN exhibited a significant decline in post-PCI QoL across all domains compared to the non-CIN group (p < 0.05). CIN, older age, diabetes, lack of hydration protocol use, prolonged hospital stay, and lower baseline QoL were independent predictors of poorer QoL outcomes. Comorbidities were more prevalent in the CIN group, including diabetes (64.0 % vs. 47.8 %), hypertension (68.0 % vs. 60.8 %), and CKD Stage 3 or worse (28.0 % vs. 8.6 %) (all p < 0.05). CIN patients more frequently underwent PCI for acute coronary syndrome, received higher contrast volumes, and had lower use of preventive measures. Post-PCI complications such as heart failure (36.0 %), dialysis requirement (32.0 %), and prolonged hospital stays (60.0 %) were significantly higher in CIN patients.

Conclusion: CIN adversely affects QoL following PCI, particularly in high-risk patients. Preventive strategies and early intervention are essential to mitigate CIN-related complications and improve patient-centered outcomes. Further prospective, multi-center studies are warranted.

目的:本研究旨在评估造影剂肾病(CIN)对巴基斯坦经皮冠状动脉介入治疗(PCI)患者生活质量(QoL)的影响。方法:对5325例行PCI的患者进行回顾性队列研究,分为CIN组(n = 1250)和非CIN组(n = 4075)。记录人口统计学、临床特征和手术细节。在PCI前后使用标准化问卷评估生活质量,包括身体功能、疼痛、活动能力、焦虑/抑郁和整体健康状况。统计分析比较各组之间的生活质量评分和确定的变化预测因素。结果:与非CIN组相比,发生CIN的患者在pci后各领域的生活质量均显著下降(p < 0.05)。CIN、年龄较大、糖尿病、缺乏水合治疗方案、延长住院时间和较低的基线生活质量是较差生活质量结果的独立预测因子。CIN组的合并症更为普遍,包括糖尿病(64.0%比47.8%)、高血压(68.0%比60.8%)和CKD 3期及以上(28.0%比8.6%)(均p < 0.05)。CIN患者因急性冠脉综合征接受PCI的频率更高,造影剂体积更高,预防措施使用率更低。pci术后并发症如心衰(36.0%)、透析需求(32.0%)和延长住院时间(60.0%)在CIN患者中明显更高。结论:CIN对PCI术后的生活质量有不利影响,尤其是对高危患者。预防策略和早期干预对于减轻cin相关并发症和改善以患者为中心的结果至关重要。进一步的前瞻性、多中心研究是必要的。
{"title":"Quality of Life Changes Post-PCI With Contrast-induced Nephropathy.","authors":"Uzair N Malik, Kashif Iltaf, Maria M Ahmed Babiker, Prem Chand, Rakesh Kumar, Areesha Qureshi, Aajay Kumar, Muhammad H Bari, Ali Karim, Sameet Kumar, Fnu Shweta, Fnu Rumela, Fnu Payal, Abida Parveen","doi":"10.55729/2000-9666.1545","DOIUrl":"https://doi.org/10.55729/2000-9666.1545","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the impact of contrast-induced nephropathy (CIN) on quality of life (QoL) in patients undergoing percutaneous coronary intervention (PCI) in Pakistan.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted involving 5325 patients who underwent PCI, divided into CIN (n = 1250) and non-CIN (n = 4075) groups. Demographics, clinical characteristics, and procedural details were recorded. QoL was assessed using a standardized questionnaire before and after PCI, covering physical functioning, pain, mobility, anxiety/depression, and overall health. Statistical analyses compared QoL scores between groups and identified predictors of change.</p><p><strong>Results: </strong>Patients who developed CIN exhibited a significant decline in post-PCI QoL across all domains compared to the non-CIN group (p < 0.05). CIN, older age, diabetes, lack of hydration protocol use, prolonged hospital stay, and lower baseline QoL were independent predictors of poorer QoL outcomes. Comorbidities were more prevalent in the CIN group, including diabetes (64.0 % vs. 47.8 %), hypertension (68.0 % vs. 60.8 %), and CKD Stage 3 or worse (28.0 % vs. 8.6 %) (all p < 0.05). CIN patients more frequently underwent PCI for acute coronary syndrome, received higher contrast volumes, and had lower use of preventive measures. Post-PCI complications such as heart failure (36.0 %), dialysis requirement (32.0 %), and prolonged hospital stays (60.0 %) were significantly higher in CIN patients.</p><p><strong>Conclusion: </strong>CIN adversely affects QoL following PCI, particularly in high-risk patients. Preventive strategies and early intervention are essential to mitigate CIN-related complications and improve patient-centered outcomes. Further prospective, multi-center studies are warranted.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"6-11"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of Antiviral Treatment for Hospitalized Patients With Mild-to-moderate COVID-19 at High Risk for Disease Progression. 轻中度疾病进展高危住院患者抗病毒治疗的应用
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1552
Michael P Iannetti, Katie Barnes, Stephen Varga, Suzanne Kemper, Elaine D Mattox

Clinicians frequently encounter patients in the hospital with mild-to-moderate COVID-19 who are at high risk for disease progression. Antiviral drugs reduce the rate of progression to severe COVID-19 when given to these patients within 5-7 days of symptom onset. To look at the utilization of antiviral medications in hospitalized patients with mild-to-moderate COVID-19, a detailed chart review was conducted of 500 randomly selected patients from the Charleston Area Medical Center COVID-19 Registry. We identified 124 patients with mild-to-moderate COVID-19 who were eligible for antiviral treatment. Only 41 of the 124 patients (33.1 %) received antiviral treatment. Providers listed mild symptoms as the most common reason (74.7 %) that antiviral treatment was not started. These findings show that antiviral medications are underutilized in treating high-risk hospitalized patients with mild-to-moderate COVID-19 to prevent disease progression.

临床医生经常在医院遇到患有轻至中度COVID-19的患者,这些患者有很高的疾病进展风险。在症状出现后5-7天内给予这些患者抗病毒药物可降低进展为严重COVID-19的速度。为了了解轻中度COVID-19住院患者抗病毒药物的使用情况,研究人员对查尔斯顿地区医疗中心COVID-19登记处随机选择的500名患者进行了详细的图表回顾。我们确定了124名有资格接受抗病毒治疗的轻中度COVID-19患者。124例患者中只有41例(33.1%)接受了抗病毒治疗。提供者将轻微症状列为未开始抗病毒治疗的最常见原因(74.7%)。这些发现表明,在治疗轻中度COVID-19住院高危患者以预防疾病进展方面,抗病毒药物未得到充分利用。
{"title":"Utilization of Antiviral Treatment for Hospitalized Patients With Mild-to-moderate COVID-19 at High Risk for Disease Progression.","authors":"Michael P Iannetti, Katie Barnes, Stephen Varga, Suzanne Kemper, Elaine D Mattox","doi":"10.55729/2000-9666.1552","DOIUrl":"https://doi.org/10.55729/2000-9666.1552","url":null,"abstract":"<p><p>Clinicians frequently encounter patients in the hospital with mild-to-moderate COVID-19 who are at high risk for disease progression. Antiviral drugs reduce the rate of progression to severe COVID-19 when given to these patients within 5-7 days of symptom onset. To look at the utilization of antiviral medications in hospitalized patients with mild-to-moderate COVID-19, a detailed chart review was conducted of 500 randomly selected patients from the Charleston Area Medical Center COVID-19 Registry. We identified 124 patients with mild-to-moderate COVID-19 who were eligible for antiviral treatment. Only 41 of the 124 patients (33.1 %) received antiviral treatment. Providers listed mild symptoms as the most common reason (74.7 %) that antiviral treatment was not started. These findings show that antiviral medications are underutilized in treating high-risk hospitalized patients with mild-to-moderate COVID-19 to prevent disease progression.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"25-29"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bullous Myringitis in an Adult With Chronic Noise Exposure. 慢性噪音暴露成人的大疱性耳膜炎。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1555
Oluchi Ndulue, Faisal Elali, Sahibjot Sandhu, Michal Preis, Michael Marcelin

Bullous Myringitis (BM) is an acute painful infection in which vesicles or bullae form on the tympanic membrane. It is rare in adults and could be present with acute otitis media (AOM) if the middle ear is involved. This case report details a 55-year-old male with a history of recurrent childhood ear infections, chronic military noise exposure, smoking, and Crohn's disease presenting with severe right ear pain, hearing loss, and fever. Examination revealed signs of AOM with perforations in the tympanic membrane and purulent drainage. Initial management included antibiotics and analgesics, but symptoms progressed, requiring further investigation. Imaging showed complete opacification of the R ear structures without bone erosion. Despite initial treatment, the patient's condition worsened with bilateral hearing loss and intermittent peripheral vertigo. Ear, nose and throat (ENT) consultation and advanced diagnostics led to a diagnosis of BM with AOM, and asymmetric sensorineural hearing loss. The treatment was escalated to include high-dose steroids, azithromycin, valacyclovir, and daily aspiration of effusion. His symptoms improved, and he was discharged with oral antibiotics and scheduled follow-up. This case highlights the complexity of diagnosing BM that complicates AOM in an adult and the importance of detailed history, underlying past medical conditions pertinent to early diagnosis, consideration of less common pathogens, and comprehensive treatment.

大疱性鼓膜炎(BM)是一种急性疼痛性感染,在鼓膜上形成囊泡或大泡。它是罕见的,在成人和可能存在急性中耳炎(AOM),如果中耳受累。本病例报告详细介绍了一名55岁男性,他有反复发作的儿童期耳部感染、长期暴露于军队噪音、吸烟和克罗恩病的病史,表现为严重的右耳疼痛、听力丧失和发烧。检查显示中耳炎的征象,鼓膜穿孔和脓性引流。最初的治疗包括抗生素和镇痛药,但症状进展,需要进一步调查。影像学显示右耳结构完全混浊,无骨侵蚀。尽管初步治疗,患者病情恶化,双侧听力丧失和间歇性周围性眩晕。耳鼻喉科(ENT)会诊和高级诊断导致BM合并AOM和不对称感音神经性听力损失的诊断。治疗逐渐升级,包括大剂量类固醇、阿奇霉素、valacyclovir和每日积液抽吸。他的症状有所改善,他在口服抗生素和计划随访后出院。本病例强调了诊断成年AOM并发BM的复杂性,以及详细病史、与早期诊断相关的潜在病史、考虑不常见病原体和综合治疗的重要性。
{"title":"Bullous Myringitis in an Adult With Chronic Noise Exposure.","authors":"Oluchi Ndulue, Faisal Elali, Sahibjot Sandhu, Michal Preis, Michael Marcelin","doi":"10.55729/2000-9666.1555","DOIUrl":"https://doi.org/10.55729/2000-9666.1555","url":null,"abstract":"<p><p>Bullous Myringitis (BM) is an acute painful infection in which vesicles or bullae form on the tympanic membrane. It is rare in adults and could be present with acute otitis media (AOM) if the middle ear is involved. This case report details a 55-year-old male with a history of recurrent childhood ear infections, chronic military noise exposure, smoking, and Crohn's disease presenting with severe right ear pain, hearing loss, and fever. Examination revealed signs of AOM with perforations in the tympanic membrane and purulent drainage. Initial management included antibiotics and analgesics, but symptoms progressed, requiring further investigation. Imaging showed complete opacification of the R ear structures without bone erosion. Despite initial treatment, the patient's condition worsened with bilateral hearing loss and intermittent peripheral vertigo. Ear, nose and throat (ENT) consultation and advanced diagnostics led to a diagnosis of BM with AOM, and asymmetric sensorineural hearing loss. The treatment was escalated to include high-dose steroids, azithromycin, valacyclovir, and daily aspiration of effusion. His symptoms improved, and he was discharged with oral antibiotics and scheduled follow-up. This case highlights the complexity of diagnosing BM that complicates AOM in an adult and the importance of detailed history, underlying past medical conditions pertinent to early diagnosis, consideration of less common pathogens, and comprehensive treatment.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"53-56"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Spondylodiscitis Due to Actinotignum schaalii in a Patient With Crohn's Disease. 克罗恩病患者因沙利放线菌引起的罕见脊柱炎1例。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1557
Austin Tiesenga, Thomas R Birris, William Schreiner, David Malaka, Rafeek Woods, Michael S Wang

We report a case of a 55-year-old male with a history of Crohn's Disease who presented for acute on chronic worsening back pain. He was found to have spondylodiscitis with adjacent myositis secondary to an uncommon urinary tract infection pathogen, Actinotignum schaalii. He underwent interventional radiology disc biopsy and open surgical biopsy with culture. He was successfully treated with a six-week course of IV daptomycin and ceftriaxone.

我们报告一个病例55岁的男性与克罗恩病的历史谁提出了急性和慢性恶化的背部疼痛。他被发现患有脊椎椎间盘炎并伴有继发性肌炎,继发于一种罕见的尿路感染病原体,沙利放线菌。他接受了介入放射学椎间盘活检和开放性手术活检并培养。他成功地接受了为期六周的静脉注射达托霉素和头孢曲松治疗。
{"title":"A Rare Case of Spondylodiscitis Due to <i>Actinotignum schaalii</i> in a Patient With Crohn's Disease.","authors":"Austin Tiesenga, Thomas R Birris, William Schreiner, David Malaka, Rafeek Woods, Michael S Wang","doi":"10.55729/2000-9666.1557","DOIUrl":"https://doi.org/10.55729/2000-9666.1557","url":null,"abstract":"<p><p>We report a case of a 55-year-old male with a history of Crohn's Disease who presented for acute on chronic worsening back pain. He was found to have spondylodiscitis with adjacent myositis secondary to an uncommon urinary tract infection pathogen, <i>Actinotignum schaalii</i>. He underwent interventional radiology disc biopsy and open surgical biopsy with culture. He was successfully treated with a six-week course of IV daptomycin and ceftriaxone.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"57-60"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infective Endocarditis With Coronary Artery Embolization and Multisystem Involvement in a Patient With a History of IV Drug Use: A Case Report. 有静脉用药史的感染性心内膜炎伴冠状动脉栓塞及多系统累及1例报告。
IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-14 eCollection Date: 2025-01-01 DOI: 10.55729/2000-9666.1549
Abdul Moiz, Khawaja O Omar

Background: Infective endocarditis (IE) is a rare cause of myocardial infarction (MI). In contrast to other embolic phenomena associated with IE, the incidence of coronary embolism is <1 % with a mortality rate of >65 %. Common risk factors of IE include intravenous drug use (IVDU), hemodialysis and the use of cardiac devices. We present a unique case of multiple coronary artery involvement on 2 separate occasions highlighting the need for increased awareness among healthcare professionals.

Case report: A 38-year-old female with history of IVDU, hepatitis B and C presented with acute chest pain and was found to have NSTEMI and active aortic valve vegetation. Left heart catheterization (LHC) revealed an occlusion of the right coronary artery (RCA), which was treated with stent placement. However, on experiencing ventricular fibrillation on hospital day 2, a repeat cardiac catheterization revealed a re-occlusion of RCA proximal to the stent as well as occlusion of the first obtuse marginal artery (OM1). Subsequent investigations also revealed multiple intraparenchymal hemorrhages and probable renal infarcts. The involvement of multiple systems, as well as the occlusion of multiple coronary arteries on separate occasions distinguishes this case from previously reported cases.

Conclusion: Timely intervention is critical in the management of MI due to septic embolism. A high index of suspicion and immediate action can be lifesaving. Early diagnostic imaging and percutaneous or surgical interventions can improve patient outcomes. Greater awareness of multisystem and multi-coronary artery embolic phenomena is needed.

背景:感染性心内膜炎(IE)是引起心肌梗死(MI)的罕见原因。与其他与IE相关的栓塞现象相比,冠状动脉栓塞的发生率为65%。IE的常见危险因素包括静脉药物使用(IVDU)、血液透析和心脏装置的使用。我们提出了一个独特的情况下,多冠状动脉累及在2个不同的场合强调需要提高意识的医护人员。病例报告:一名38岁女性,有IVDU,乙肝和丙肝病史,急性胸痛,发现有NSTEMI和活动性主动脉瓣植被。左心导管(LHC)显示右冠状动脉(RCA)闭塞,采用支架置入治疗。然而,在住院第2天发生心室颤动时,重复心导管检查显示支架近端的RCA再次闭塞,以及第一钝缘动脉(OM1)闭塞。随后的检查也显示多发性肾实质内出血和可能的肾梗死。累及多个系统,以及多个冠状动脉在不同场合的闭塞,使本病例与以前报道的病例区别开来。结论:及时干预对脓毒性栓塞性心肌梗死的治疗至关重要。高度怀疑和立即采取行动可以挽救生命。早期诊断成像和经皮或手术干预可以改善患者的预后。需要提高对多系统和多冠状动脉栓塞现象的认识。
{"title":"Infective Endocarditis With Coronary Artery Embolization and Multisystem Involvement in a Patient With a History of IV Drug Use: A Case Report.","authors":"Abdul Moiz, Khawaja O Omar","doi":"10.55729/2000-9666.1549","DOIUrl":"https://doi.org/10.55729/2000-9666.1549","url":null,"abstract":"<p><strong>Background: </strong>Infective endocarditis (IE) is a rare cause of myocardial infarction (MI). In contrast to other embolic phenomena associated with IE, the incidence of coronary embolism is <1 % with a mortality rate of >65 %. Common risk factors of IE include intravenous drug use (IVDU), hemodialysis and the use of cardiac devices. We present a unique case of multiple coronary artery involvement on 2 separate occasions highlighting the need for increased awareness among healthcare professionals.</p><p><strong>Case report: </strong>A 38-year-old female with history of IVDU, hepatitis B and C presented with acute chest pain and was found to have NSTEMI and active aortic valve vegetation. Left heart catheterization (LHC) revealed an occlusion of the right coronary artery (RCA), which was treated with stent placement. However, on experiencing ventricular fibrillation on hospital day 2, a repeat cardiac catheterization revealed a re-occlusion of RCA proximal to the stent as well as occlusion of the first obtuse marginal artery (OM1). Subsequent investigations also revealed multiple intraparenchymal hemorrhages and probable renal infarcts. The involvement of multiple systems, as well as the occlusion of multiple coronary arteries on separate occasions distinguishes this case from previously reported cases.</p><p><strong>Conclusion: </strong>Timely intervention is critical in the management of MI due to septic embolism. A high index of suspicion and immediate action can be lifesaving. Early diagnostic imaging and percutaneous or surgical interventions can improve patient outcomes. Greater awareness of multisystem and multi-coronary artery embolic phenomena is needed.</p>","PeriodicalId":15460,"journal":{"name":"Journal of Community Hospital Internal Medicine Perspectives","volume":"15 6","pages":"49-52"},"PeriodicalIF":0.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Community Hospital Internal Medicine Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1